World Trade Organization (WTO) members implemented 165 trade-restrictive measures out of the 363 new trade and trade-related measures between October 2019 and May 2020, accounting for 45 percent.
The new restrictions covered merchandise worth an estimated $ 423.1 billion.
According to WTO Director-General Roberto Azevêdo, the report reveals that world trade continues to be affected by import-restrictive measures, at a time when economies will need trade to rebuild from the effects of the Covid-19 crisis.
But he added that WTO members also introduced import-facilitating measures on an impressive scale, and began scaling back trade restrictions introduced earlier in the pandemic.
Fifty-six new trade-restrictive measures were not related to the pandemic, mainly stricter export customs procedures, export duties, import bans, and tariff increases.
Out of the total new measures, 256 were pandemic-related, accounting for 71 percent of the total trade and trade-related measures.
These pandemic-related measures could be categorized in two waves.
In the early stages of the pandemic, several of the restricted the free flow of trade.
By the middle of May, 57 percent of all measures facilitated trade.
The report also showed that WTO members were moving towards trade-facilitating policies during the period, implementing 51 new trade-facilitating measures not related to Covid-19.
These measures consisted mainly of eliminating import taxes, eliminating or reducing import tariffs, reducing export duties, and simplifying customs procedures.


Coty Revenue Beats Estimates as Beauty Demand Holds Firm
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion
Anthropic Revenue Run Rate Hits $65 Billion as IPO Plans Accelerate
BofA Sees Micron EPS Topping $230 by 2030, Backs Major Stock Upside
Shein Targets $26B-$27B Valuation for Hong Kong IPO
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme
Samsung Eyes $72 Billion Shareholder Return Plan as AI Chip Boom Fuels Profits
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Google to Buy Spirit Airlines Business Data for $10 Million to Train AI
Google to Move All Pixel Production Out of China by 2027 



